Found: 15
Select item for more details and to access through your institution.
Does Industry Really Develop Less Medicine With Clinical Benefit?—Reply.
- Published in:
- JAMA Internal Medicine, 2024, v. 184, n. 5, p. 587, doi. 10.1001/jamainternmed.2024.0180
- By:
- Publication type:
- Article
Provenance and Clinical Benefit of Medicines Introduced to the French Market, 2008 to 2018.
- Published in:
- JAMA Internal Medicine, 2024, v. 184, n. 1, p. 46, doi. 10.1001/jamainternmed.2023.6249
- By:
- Publication type:
- Article
Assessment of Devices, Diagnostics and Digital Technologies: A Review of NICE Medical Technologies Guidance.
- Published in:
- Applied Health Economics & Health Policy, 2019, v. 17, n. 2, p. 189, doi. 10.1007/s40258-018-0438-y
- By:
- Publication type:
- Article
Assessment of technical errors and validation processes in economic models submitted by the company for NICE technology appraisals.
- Published in:
- 2020
- By:
- Publication type:
- journal article
NICE's evaluations of medicines authorized by EMA with conditional marketing authorization or under exceptional circumstances.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The impact of parallel regulatory–health technology assessment scientific advice on clinical development. Assessing the uptake of regulatory and health technology assessment recommendations.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 1013, doi. 10.1111/bcp.13524
- By:
- Publication type:
- Article
How aligned are the perspectives of EU regulators and HTA bodies? A comparative analysis of regulatory-HTA parallel scientific advice.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 82, n. 4, p. 965, doi. 10.1111/bcp.13023
- By:
- Publication type:
- Article
Costs and Causes of Oncology Drug Attrition With the Example of Insulin-Like Growth Factor-1 Receptor Inhibitors.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 7, p. e2324977, doi. 10.1001/jamanetworkopen.2023.24977
- By:
- Publication type:
- Article
The Origin of First‐in‐Class Drugs: Innovation Versus Clinical Benefit.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 2, p. 342, doi. 10.1002/cpt.3110
- By:
- Publication type:
- Article
A new fetal RHD genotyping test: costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales.
- Published in:
- 2011
- By:
- Publication type:
- journal article
A new fetal RHD genotyping test: Costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales.
- Published in:
- BMC Pregnancy & Childbirth, 2011, v. 11, n. 1, p. 5, doi. 10.1186/1471-2393-11-5
- By:
- Publication type:
- Article
Integrating health technology assessment requirements in the clinical development of medicines: the experience from NICE scientific advice.
- Published in:
- European Journal of Clinical Pharmacology, 2017, v. 73, n. 3, p. 297, doi. 10.1007/s00228-016-2174-2
- By:
- Publication type:
- Article
The early impact of the global lockdown on post-secondary students and staff: A global, descriptive study.
- Published in:
- SAGE Open Medicine, 2022, v. 10, p. 1, doi. 10.1177/20503121221074480
- By:
- Publication type:
- Article
The early impact of the global lockdown on post-secondary students and staff: A global, descriptive study.
- Published in:
- SAGE Open Medicine, 2022, v. 10, p. 1, doi. 10.1177/20503121221074480
- By:
- Publication type:
- Article
Application of ELI-P-Complex Method in Clinical Obstetrics.
- Published in:
- American Journal of Reproductive Immunology, 2007, v. 57, n. 4, p. 294, doi. 10.1111/j.1600-0897.2007.00479.x
- By:
- Publication type:
- Article